drugset / Trial / NCT03917940

Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

NCT03917940

Completed 70 enrolled Damanhour University
RandomizedParallel-groupSingle-blindSupportive care

Summary

study the effect of omega 3 fatty acids on blood glucose, lipids profile, serum Irisin and sirtuin-1 in type 2 diabetic mellitus patients treated with glimepiride.

Timeline

Start
2019-01-31
Primary completion
2020-05-01
Completion
2020-05-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glimepiride Small molecule 2 mg Oral
Comparator Glimepiride Small molecule 3 mg Oral

Indications

No indication recorded.